Robert Crutchfield
SlowingNamed in filings at Harbert Growth Partners
- Board seats filed
- 8
Named in filings at Harbert Growth Partners
all filings on record
last 24 months
from a verified or cited source
| Synaptrix | Medical devices | November 2024 | Harbert Venture Partners, Hatteras Venture Partners |
| Pictor Labs | Biotech & pharma | August 2024 | Harbert Venture Partners |
| VenoStent | Medical devices | July 2023 | Harbert Venture Partners |
| Pleural Dynamics | Medical devices | May 2023 | Harbert Venture Partners |
| OrbitalRx | Digital health | May 2023 | Harbert Venture Partners |
| SHIPT | E-commerce & marketplaces | June 2016 | Greycroft, Harbert Venture Partners |
| IngagePatient | Digital health | June 2014 | Harbert Venture Partners |
| WellCentive | Digital health | April 2014 | Harbert Venture Partners, Noro-Moseley Partners |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Robert Crutchfield on the board, based on 8 filed seats with a verified or cited source.